PEG-INTERFERON-α-2A versus PEG-INTERFERON-α-2B in combination with ribavirin in naives patients with chronic hepatitis C and HIV infection

被引:0
|
作者
Magni, C. [1 ]
Argenteri, B. [1 ]
Capetti, A. F. [1 ]
Corbellino, M. [2 ]
Giani, G.
Giuliani, G. [1 ]
Lombardi, A. [3 ]
Niero, F. [1 ]
Pastecchia, C. [1 ]
Terzi, R. [1 ]
Zanchetta, N. [3 ]
Rizzardini, G. [1 ]
机构
[1] Luigi Sacco Hosp, Div Infect Dis 1, Milan, Italy
[2] Luigi Sacco Hosp, Clin Infect Dis, Milan, Italy
[3] Luigi Sacco Hosp, Microbiol Unit, Milan, Italy
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:89 / 89
页数:1
相关论文
共 50 条
  • [1] Effect of interferon-λ4 on treatment response to peg-interferon-α-2a and ribavirin in patients with chronic hepatitis C
    Staettermayer, Albert
    Hofer, Harald
    Rutter, Karoline
    Beinhardt, Sandra
    Scherzer, Thomas-Matthias
    Steindl-Munda, Petra E.
    Ferenci, Peter
    [J]. HEPATOLOGY, 2013, 58 : 1124A - 1125A
  • [3] Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C-related mixed cryoglobulinemia
    Saadoun, David
    Rigon, Mathieu Resche
    Sene, Damien
    Terrier, Benjamin
    Karras, Alexandre
    Perard, Laurent
    Schoindre, Yoland
    Coppere, Brigitte
    Blanc, Francois
    Musset, Lucile
    Piette, Jean-Charles
    Rosenzwajg, Michele
    Cacoub, Patrice
    [J]. BLOOD, 2010, 116 (03) : 326 - 334
  • [4] Accordion Index:: A new tool for the prediction of the efficacy of peg-interferon-α-2b and ribavirin combination therapy for chronic hepatitis C
    Satoh, Takeaki
    Masumoto, Akihide
    [J]. HEPATOLOGY RESEARCH, 2008, 38 (03) : 315 - 318
  • [6] Efficacy of peg-interferon-α-2a plus ribavirin for patients aged 60 years and older with chronic hepatitis C in Korea
    Sinn, Dong Hyun
    Shin, Su Rin
    Kil, Jae Sook
    Kim, Jeong
    Gwak, Geum-Youn
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Yoo, Byung Chul
    Paik, Seung Woon
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (03) : 469 - 476
  • [7] Blood cell, liver function, and response changes by PEG-interferon-α2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C
    Kim, Ke Ih
    Kim, Soo Ryang
    Sasase, Noriko
    Akimoto, Yoko
    Shikata, Mao
    Ohtani, Aya
    Hirooka, Teruko
    Tanaka, Kazuhiko
    [J]. HEPATOLOGY INTERNATIONAL, 2008, 2 (01) : 111 - 115
  • [8] Blood cell, liver function, and response changes by PEG-interferon-α2b plus ribavirin with polaprezinc therapy in patients with chronic hepatitis C
    Ke Ih Kim
    Soo Ryang Kim
    Noriko Sasase
    Yoko Akimoto
    Mao Shikata
    Aya Ohtani
    Teruko Hirooka
    Kazuhiko Tanaka
    [J]. Hepatology International, 2008, 2 : 111 - 115
  • [9] Response to PEG-interferon-α2b monotherapy or in combination with ribavirin in HCV-infected patients:: preliminary experience in Venezuela
    León, RV
    Machado, T
    Ruiz, ME
    Hinestrosa, H
    Páez, R
    Torres, B
    Quiróz, E
    Zuramay, C
    Aparcero, M
    Domínguez, M
    Gamboa, A
    Wanderlinder, J
    Beker, B
    Noguera, M
    [J]. ANTIVIRAL THERAPY, 2002, 7 (04) : L93 - L94
  • [10] 2′-,5′-oligoadenylate synthetase response ratio predicting virological response to PEG-interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
    Kim, K. -I.
    Kim, S. -R.
    Sasase, N.
    Taniguchi, M.
    Harada, S.
    Kinoshita, K.
    Kim, S. -H.
    Akimoto, Y.
    Shikata, M.
    Kimura, N.
    Izawa, S.
    Ohtani, A.
    Nakao, K.
    Motojima, M.
    Kinoshita, M.
    Hirai, M.
    Ohzu, M.
    Hirooka, T.
    Nabeshima, S.
    Ishii, F.
    Tanaka, K.
    Hotta, H.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2006, 31 (05) : 441 - 446